Iranian-born Dr. David Samadi grew up in a community where Persian-Jewish history and culture were amalgamated. He left Iran at age 15 when the revolution ended in 1979. He studied in Belgium and London before settling in the United States and completed secondary education in Roslyn, New York. He earned his degree in biochemistry at Stony Brook University on a full scholarship.
A Medical Dream
Dr. David Samadi attended the State University of New York where he earned his medical degree. During his postgraduate training, while specializing in Urology and Proctology, he attended Montefiore Medical Center and Albert Einstein College of Medicine in 2001 respectively. He was an oncology fellow in proctology at Memorial Sloan Kettering in 2001 and worked at Henri Mondor Hospital Creteil in France for a robotic radical prostatectomy in 2002.
The Invention of Change
Dr. David Samadi hoped to alleviate the prostate cancer scene. With Samadi Modified Advanced Robotic Treatment (SMART), his invention has been used on thousands of surgeries related to prostate cancer and recorded significant results. SMART was invented to promote a less invasive option for open surgeries.
Bringing Health Awareness
In order to promote consciousness of issues on health, Dr. Samadi launched DrSamadiTV.com, a web counterpart of his TV segment. He wants people to become aware of their health even in the absence of health professionals in their area. The show records one episode every week and is shown every Sunday.
Awards and Citations
With his contributions in the medical field, Dr. Samadi has been recognized by several award-giving bodies. He was named the Most Compassionate Doctor, One of the Top Doctors in America, and received the Patient’s Choice award. The New York Times and New York Magazine honored him as one the Top Doctors of America for all his medical work.
When Words Change Lives
Beyond his work in the medical world, Dr. Samadi is also known for his encouraging words. When Mitt Romney went through surgery for prostate cancer, Dr. Samadi announced the successful prognosis. In his interview with Ideamensch, he mentioned that ideas always come and go. People must remind themselves by sketching or creating something that can be associated with inspiring ideas.
Eric Lefkofksy is leading his company Tempus into the future by supporting precision medicine through data. It was when he discovered that the medical community and especially the cancer-care community was not up-to-date with the latest in technology that he decided to to something about it. Tempus aims to gather all of the loose data out there related to treating cancer patients and put it all in a database that can be accessed by the medical professionals who need it most. One of the challenges that company moved through was the fact that a lot of the data that it needed came from the notes of physicians, which are hard to translate and analyze. The company dealt with creating a system that can read these notes and put them to use. Now, Tempus and Eric Lefkofsky are looking to genome sequencing to unlock further mysteries for how to deal with the deadly disease of cancer.
Eric Lefkofsky is the Chief Executive Officer and co-founder of Tempus, which is a tech company that allows physicians to offer their cancer patients personalized care based on solid data. He also helped to found Lightbank, which is a venture fund that invests in technologies that are disruptive. Lefkofksy attended the University of Michigan and the University of Michigan Law School where he earned his Juris Doctor and has always appreciated the value of a good education. In order to help out in this area, he teaches at different business schools in the Chicago area and is also an adjunct professor at the University of Chicago Booth School of Business.
In 2006, along with his wife, Eric Lefkofsky put together the Lefkofsky Family Foundation, which is a private charity that helps to improve people’s lives. The foundation, specifically, focuses its efforts on the sectors of education, basic human rights, the arts and culture, and medicine. Mr. Lefkofsky is also a trustee of The Museum of Science and Industry and World Business Chicago, Lurie Children’s Hospital of Chicago, and The Art Institute of Chicago. It his hope to see a better world and a better Chicago during his lifetime.
David Samadi, in his contribution in the Huffington post, welcomed the news of the former Republican presidential candidate’s prostate cancer treatment. Dr. David Samadi said that prostate cancer when diagnosed and treated early, results in better chances of survival for men. Other high profile men who have been treated of the same include Collin Powell and John Kerry. He noted that advanced age of the individuals and their health history are some of the factors that led to the diagnosis.
Dr. Samadi also encouraged surgical treatment of cancer, stating that use of radiation might result in further complications. He said that using radiation to treat prostate cancer might result in other cancers due to the effect of radiation. Men treated with radiation were twice likely to die than men treated via surgery, those treated via surgery were also likely to live longer than their counterparts treated via radiation. Prostate cancer is common among older men, with the average age of those suffering from it being 66.
David Samadi and his brother came to the United States from Iran during the 1979 revolution in Iran. He studied in Belgium then went to London before getting into the United States. He graduated from Rosyl High in New York and got a full scholarship at Stony Brook to study Biochemistry. He graduated in 1994 and then trained in urology as a postgraduate trainee for four years in different medical centers. Dr. Samadi then did his medical fellowship in France, doing proctology till 2002.
Dr. Samadi began work in 2007 as the deputy head of Mt Sinai Medical School’s Urology department. He was also the robotics departmental head at the same school. He then moved to the Lenox Hill as head of similar department. He also took up a job as a professor at Hofstra North Medical School where he taught urology. His reputation as a surgical doctor is widespread, having done over 7,000 successful surgeries. Dr. Samadi has also been acclaimed for developing SMART; an innovative way of surgical treatment of prostate cancer. His specialty is in the treatment of prostate cancer, bladders, and kidneys. He prefers handling patients in small groups so as to better understand the best way or technique to use in treating each patient. He has been named as the highest earning doctor in New York City, making over $7.6 million. Mr. Samadi offers free consultations for any man who has been diagnosed with prostate cancer.
Dr. David Samadi is a surgeon and urologist who has practiced in more than 40 countries. He is an expert at using advanced surgical robots that assist him in the surgical room. In the past he was the host of a popular weekend tv show that was focused on medical issues. The type of surgery he most often performs is on men who have developed prostate cancer.
While Dr. David Samadi was successful at the beginning of his career, it was his going to Franch to study how they performed urologic surgery that really advanced his career. He learned their method which was to use laparoscopic technology while performing these types of operations. He spent a year in Creteil with other skilled surgeons who taught him everything they knew.
Having been born in Iran, after the Iranian Revolution he left the country as a teenager as he was Persian Jew and so in danger. Just he and his brother were able to leave and eventually they ended up in New York. He attended Roslyn High School and then earned his bachelor’s degree. It was a the Memorial Sloan Kettering Cancer Center that he learned the knowledge he needed to become a urologist.
In 2007, Dr. David Samadi came up with a completely new way of doing surgery using advanced robotic techniques. Commonly, these types of surgeries have a number of bad effects as they damage the nerves. His new technique does not hurt the nerves and so these side effects are avoided. He patented this technique in 2008.
For four years, Dr. David Samadi was the host for Sunday Housecall. This Fox Network show was a popular source of information about advances in the field of medicine. He and other experts also answered the health questions of callers into the show.
Dr. David Samadi now practices at Lenox Hill Hospital in New York City. He is the Chief of Robotic Surgery and is also the Chairman of the Urology department. Over the course of his career he has completed over 7000 robotic prostate surgeries. Over 80% of his patients are able to regain full sexual function which is a very good stat in the industry. Additionally, almost 90% of his patients end up cancer free after he has performed surgery on them.
According to the article in the Forbes, billionaire Eric Lefkofsky created his fortune saving clients’ money on restaurants and travel with the Groupon GRPN +2.91%. He’s the co-founder of the Chicago-based Tempus together with Brad Keywell, which focuses on the use of genomic sequencing in helping doctors in customizing cancer treatments.
Recently, Lefkofsky announced thatTempus had raised 70 million dollars in the company’s series C funding round, which was from the investors New Enterprise Associates and Revolution Growth. The funding was part of the 130 million dollars raised since Eric Lefkofsky co-founded Tempus in the year 2015. The current fundraising puts Tempus valuation at roughly 700 million dollars.
Keywell and Lefkofsky, who is CEO, have invested in each Tempus fundraising round and remain its biggest individual investors. The previous year, Lefkofsky told the weekly business newspaper, Crain’s Chicago Business, that he was ready to invest up to 100million dollars in the firm. New investors Revolution Growth and NEA have funded companies such as personal genomics company 23andMe (NEA), salad chain Sweetgreen (Revolution), and stock trading app Robinhood funded by NEA.
Tempus uses technology to compile large genomic and clinical data quantities from cancer patients for doctors to use in cancer personalize treatment. Last year, Tempus announced partnerships with the Cleveland Clinic, Mayo Clinic, among others. Tempus said that it was building the largest library of molecular and clinical data for personalizing and improving cancer care. Lefkofsky said that across healthcare, and in oncology more broadly, datasets had historically been small as well as disorganized. However, technology had created room for new possibilities. For the first time, now it’s possible to amass large amounts of clinical and molecular data and make it benefit patients by putting it to work
Lefkofsky is a Jewish and was raised in Southfield, Michigan. In 1987, He graduated from Southfield-Lathrup High School. He attended the UMich (University of Michigan), where he graduated with honors in the year 1991. Lefkofsky continued at Michigan Law to earn his Juris Doctor in 1993. He’s on the BOD (board of directors) at the Chicago-based Children’s Memorial Hospital, The (AIC) Art Institute of Chicago, and MSI. He’s also Steppenwolf Theatre Company’s Trustee. He serves as co-chairman of World Business Chicago’s Technology Council.
Eric Lefkofsky is one of the more versatile businesspeople in the United States. Over a number of years, he has started up and ran many successful companies. All of these companies are in a variety of industries such as healthcare, transportation and commerce. With all of the companies he has founded, Eric has been able to meet the market demands for many consumers and businesses. There are a number of companies that Eric has founded with one of them being Tempus. Along with this company, he has founded Lightbank which invests in disruptive technology sources. He is the founder of Groupon which offers a number of discounts for products being sold on the internet. Eric is also the co founder to Uptake Technologies which is one of the top predictive analytics companies in the world to learn more: https://www.insidephilanthropy.com/guide-to-individual-donors/eric-lefkofsky.html click here.
There are some other companies that Eric has founded during his career. He founded Mediaocian which offers media procurement technology. Lefkofsky has also started up a company that offers technology transportation and logistics outsourcing called Echo Global Logistics. Inner Workings is a company that specializes in offers managed print and promotional solutions. These are the companies that have allowed Eric to become one of the most notable businesspeople in the entire nation. As well as being an entrepreneur, Eric has highly educated as he graduated law school at the University of Michigan.
While Eric has founded a number of successful companies, his most notable one is Tempus. The company known as Tempus is a firm that uses technology to help fight cancer for a number of patients. As a result, it is one of the most innovative companies in the healthcare industry. With the services of this company, physicians are able to provide the most personalized cancer treatment to their patients. They are able to use an interactive analytical and machine learning platform in order to provide the best care patients treatment. Along with providing an analytical machine, Tempus also provides analysis of both the molecular and therapeutic data. This will allow physicians to make treatment decisions in real time based on data.
As well as being an active entrepreneur, Eric is also quite involved in a number of philanthropic activities. One of the main charitable organizations that Eric has founded is Lefkofsky Family Foundation. He founded this organization in 2006 which has helped advance a number of livelihood initiatives in his local community. Along with being the founder of the Lefkofsky Foundation, Eric also serves as the Trustee of Lurie Children’s Hospital of Chicago. He is also involved with some other organizations such as the Art Institute of Chicago and the Museum of Science and Industry and World Business Chicago.
Like a number of other entrepreneurs and professionals, Eric has a considerable presence on social media. He has accounts with all of the major social media sites such as Facebook, Twitter and LinkedIn. With these sites, Eric has been able to promote his businesses as well as his latest experiences as an entrepreneur. He often provides updates on the accomplishments of his companies as well as any events that he is going to attend. Anyone looking to stay in contact with Eric will be able to do so by following his social media sites. These sites are also ideal for current and prospective customers who are looking to get more information about his business offerings.